Quote | Maxpro Capital Acquisition Corp. (NASDAQ:JMAC)
Last: | $10.81 |
---|---|
Change Percent: | -2.64% |
Open: | $11.824 |
Close: | $10.81 |
High: | $12.72 |
Low: | $10.08 |
Volume: | 117,874 |
Last Trade Date Time: | 03/29/2023 03:00:00 am |
News | Maxpro Capital Acquisition Corp. (NASDAQ:JMAC)
FOSTER CITY, Calif., March 30, 2023 (GLOBE NEWSWIRE) -- Apollomics Inc. (“Apollomics” or the “Company”), a clinical-stage biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today...
2023-03-21 16:57:51 ET Gainers: Maxpro Capital Acquisition ( JMAC ) +31% . Telesis Bio ( TBIO ) +10% . BridgeBio Pharma ( BBIO ) +4% . Hawaiian Holdings ( HA ) +2% . ProFrac Holding ( ACDC ) +2% . Losers: Adap...
Message Board Posts | Maxpro Capital Acquisition Corp. (NASDAQ:JMAC)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Maxpro Capital Acquisition Corp. Company Name:
JMAC Stock Symbol:
NASDAQ Market:
FOSTER CITY, Calif., March 30, 2023 (GLOBE NEWSWIRE) -- Apollomics Inc. (“Apollomics” or the “Company”), a clinical-stage biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today...
FOSTER CITY, Calif., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: JMAC), an innovative biopharmaceutical company committed to the discovery and development of mono- and combination-oncology therapies, today announced that the U.S. Food and Drug Administration (FDA) ha...
TAIPEI CITY, Oct. 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) (the “Company”) announced today that its sponsor, MP One Investment LLC (the “Sponsor”), deposited an additional payment in the aggregate ...